News

Researchers have generated the first “atlas” of human melanocytes. In analyzing the atlas data, it was discovered that there are different types of melanocytes and researchers predict these discoveries will lead to more targeted treatments for melanoma.

Researchers from the University of Oxford and the Ludwig Institute for Cancer Research are harnessing the viral vector technology used to create the Oxford–AstraZeneca vaccine against SARS-CoV-2 to develop a vaccine to treat cancer.

Right now, in your body, lurk thousands of cells with DNA mistakes that could cause cancer. Yet only in rare instances do these DNA mistakes, called genetic mutations, lead to a full-blown cancer. Why?

Vaccinations against human papillomavirus (HPV) are expected to yield significant reductions in the rates of throat and mouth cancers in the U.S., but will not do so until after 2045, according to a new modeling study.

Researchers have discovered a novel mechanism showing how a certain gene mutation allows tumors to evade detection by the immune system in colorectal cancer patients.

A new study from Penn Medicine shows that CAR T cells expressing a naturally occurring RNA called RN7SL1 can activate the body’s immune cells against difficult-to-treat cancers.

Two studies describe the potential of liquid biopsies to identify and track tumor growth in two very different cancers: bladder cancer and peripheral nerve tumors.

Researchers have developed a novel form of photodynamic tumor therapy for the treatment of deep tumors that works without external irradiation.

Scientists have developed a cancer vaccine that in mice was shown to trigger the immune system to destroy treatment-resistant tumor cells.

McGill University researchers have identified proteins that drive cancer stem cells. Targeting and supressing a particular protein called galectin1 could provide a more effective treatment for glioblastoma, in combination with radiation therapy.